Showing 1,495 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

Editor's pick
Forbes Magazine
7 August 2018
Pharmaceutical industry

Mylan, lambasted for EpiPen price hikes, complains of overpriced anti-HIV drugs in the United States

Editor's pick
Science
7 August 2018
Pharmaceutical industry

Court of Justice of the European Union clarifies ‘basic patent’ meaning in SPC dispute

Editor's pick
Life Sciences Intellectual Property Review
26 July 2018
Pharmaceutical industry

HIV drug may be more affordable after European court ruling

Editor's pick
The Journal
26 July 2018
New & experimental HIV treatments

The 2018 Pipeline Report

Editor's pick
TAG
24 July 2018
Pharmaceutical industry

Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

Editor's pick
Seeking Alpha
18 July 2018
Pharmaceutical industry

How Big Pharma Was Captured by the One Percent

Editor's pick
New Republic
2 July 2018
PrEP

Finns buying HIV prevention drugs from Germany because they're cheaper

Editor's pick
YLE
30 June 2018
Behaviour change interventions

“I’m on the Pill” PrEP Ads Begin Airing on National TV

Editor's pick
Poz
29 June 2018
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
25 June 2018
Pharmaceutical industry

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

Editor's pick
Reuters
25 June 2018
Pharmaceutical industry

Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player

Editor's pick
Bloomberg
21 June 2018
PrEP

#BREAKTHEPATENT

Editor's pick
breakthepatent.org
20 June 2018
New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
PrEP

With TV ads, drugmaker Gilead brings HIV prevention drug out of the closet

Editor's pick
NBC News
31 May 2018
Generic medicines

EU makes it easier for companies to produce generic medicines for export

Editor's pick
Reuters
29 May 2018
Pharmaceutical industry

AIDS Healthcare Foundation files two lawsuits against Gilead

Editor's pick
The Bay Area Reporter
21 May 2018
Access to healthcare

Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

Editor's pick
Intellectual Property Watch
14 May 2018
Side effects

Is Gilead’s Entire HIV Enterprise Built on a False Promise?

Editor's pick
Poz
10 May 2018
Pharmaceutical industry

Will the European Court of Justice put a stop to the evergreening of Truvada patents?

Editor's pick
Medicines Law & Policy
9 May 2018
Pharmaceutical industry

Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine

Editor's pick
Los Angeles Times
9 May 2018
Access to healthcare

Truvada Case Shows Civil Society’s Success With Pre-Grant Opposition

Editor's pick
Intellectual Property Watch
9 May 2018
Pharmaceutical industry

Major Win for Patients as Brazil Rejects A Key Patent on Gilead Hepatitis C Drug and European Union Denies Patent Extension to Gilead’s HIV Drug

Editor's pick
I-MAK
8 May 2018
Pharmaceutical industry

Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble

Editor's pick
Investor's Business Daily
2 May 2018